Medicare Drug Price Negotiation Program Challenged in U.S. Court of Appeals

A challenge to the novel Medicare drug price negotiation program, created to lower prescription costs, has reached the U.S. Court of Appeals for the Fifth Circuit. Pharmaceutical manufacturers and related groups nationwide are contesting the program as unconstitutional. During the oral arguments in New Orleans, Judge Jennifer Walker Elrod noted the singular nature of the…

Read More

Cranfill Sumner Expands to Washington D.C., Hires Ex-SEC Official for White-Collar Defense Practice

A North Carolina-based law firm, Cranfill Sumner, has made its debut in Washington D.C., opening an affiliate office. The firm has turned notable heads in the field by hiring a senior Securities and Exchange Commission official to helm their white-collar defense practice. Cranfill Sumner divulged on Wednesday that Christina Zaroulis Milnor, a seasoned former assistant…

Read More

Chiquita’s Colombian Operations Under Fire as Trial Hinges on Controversial Payments

As the legal proceedings of a highly anticipated trial get underway in a Florida federal court, accusations are rising high on both sides surrounding Chiquita Brands International and its operations in a Colombian banana-growing region. According to opposing lawyers, the multinational behemoth’s alleged neglect for human life in favor of high yield profits has unfolded…

Read More

Expanding Antitrust Lawsuit Challenges NCAA’s Name, Image, and Likeness Policies

On Wednesday, Florida, New York, and the District of Columbia linked arms with Tennessee and Virginia in their ongoing antitrust lawsuit against the National Collegiate Athletic Association (NCAA). The amalgamation of states are challenging the NCAA’s policies pertaining to name, image, and likeness rights of players. The focal point of the lawsuit is a request…

Read More

Yoenis Céspedes’ Companies Secure Preliminary Injunction in Baseball Bat Trademark Dispute

In an ongoing legal battle highlighting the profound intersections of sports and intellectual property law, two companies owned by former MLB player Yoenis Céspedes have recently achieved a significant early victory. A preliminary injunction has been granted against several corporations by a federal court in Florida, as part of a dispute regarding baseball bat trademarks….

Read More

FTC’s Noncompete Rule and its Impact on Nonprofit Hospitals

The recent implementation of a federal rule, banning the use of worker noncompete agreements within the healthcare sector, shines a spotlight on the nonprofit industry and notable applicability exemptions related to the new regulation. The rule, overseen by the Federal Trade Commission (FTC), generates significant relevance for the approximately 3,000 nonprofit, tax-exempt hospitals operating across…

Read More

New Jersey Judge Ends Trade Secret Dispute Between Janssen and Jiangsu Hengrui Pharmaceuticals

In a recent legal development, New Jersey’s Federal Judge approved a consent judgment barring Jiangsu Hengrui Pharmaceuticals, the Chinese drugmaker, from misappropriating trade secrets belonging to Johnson and Johnson’s pharmaceutical subsidiary, Janssen. The trade secrets in question involve the formulation of the widely used chemotherapy drug Yondelis. As part of the agreement, Jiangsu Hengrui Pharmaceuticals…

Read More

Sullivan & Cromwell Launches National Security Practice Amid Increasing Enforcement Focus

In a timely strategic move, eminent Wall Street law firm, Sullivan & Cromwell, is initiating a national security practice. This decision is made in the light of the US government’s increasing thrust on corporate enforcement blending with security interests. With prominent clients such as JPMorgan Chase & Co., Wells Fargo & Co., and Barclays, Sullivan…

Read More

SEC Intensifies Scrutiny on “Earnings Before Bad Stuff” Reporting Practices

According to a recent article published by Bloomberg, the U.S. Securities and Exchange Commission (SEC) is once again focusing its attention on ensuring organisations do not overly inflate earnings or overly emphasise optimistic results. This scrutiny seemingly arises from corporate reporting habits wherein certain undesirable elements are deliberately excluded, colloquially referred to as “earnings before…

Read More